NCT00086827View on ClinicalTrials.gov

Romidepsin in Treating Patients With Relapsed Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

November 30, 2006

Conditions
Recurrent Small Cell Lung Cancer
Interventions
DRUG

romidepsin

Given IV

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

43210

Ohio State University, Columbus

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00086827 - Romidepsin in Treating Patients With Relapsed Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter